Cancel anytime
CohBar Inc (CWBR)CWBR
- BUY Advisory
- Profitable SELL
- Loss-Inducing SELL
- Profit
- Loss
- PASS (Skip invest)*
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
11/20/2024: CWBR (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Analysis of Past Performance
Type: Stock | Upturn Star Rating | Today’s Advisory: Consider higher Upturn Star rating |
Historic Profit: -26.39% | Upturn Advisory Performance 2 | Avg. Invested days: 30 |
Profits based on simulation | Stock Returns Performance 1 | Last Close 11/20/2024 |
Type: Stock | Today’s Advisory: Consider higher Upturn Star rating |
Historic Profit: -26.39% | Avg. Invested days: 30 |
Upturn Star Rating | Stock Returns Performance 1 |
Profits based on simulation Last Close 11/20/2024 | Upturn Advisory Performance 2 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 1.45M USD |
Price to earnings Ratio - | 1Y Target Price 18 |
Dividends yield (FY) - | Basic EPS (TTM) -4.37 |
Volume (30-day avg) 1084 | Beta 1.38 |
52 Weeks Range 0.20 - 1.10 | Updated Date 11/20/2024 |
Company Size Small-Cap Stock | Market Capitalization 1.45M USD | Price to earnings Ratio - | 1Y Target Price 18 |
Dividends yield (FY) - | Basic EPS (TTM) -4.37 | Volume (30-day avg) 1084 | Beta 1.38 |
52 Weeks Range 0.20 - 1.10 | Updated Date 11/20/2024 |
Earnings Date
Report Date - | When - |
Estimate - | Actual - |
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin - | Operating Margin (TTM) - |
Management Effectiveness
Return on Assets (TTM) -48.31% | Return on Equity (TTM) -83.97% |
Valuation
Trailing PE - | Forward PE - |
Enterprise Value -10857892 | Price to Sales(TTM) - |
Enterprise Value to Revenue - | Enterprise Value to EBITDA -3.24 |
Shares Outstanding 2906930 | Shares Floating 2481730 |
Percent Insiders 15.09 | Percent Institutions 6.24 |
Trailing PE - | Forward PE - | Enterprise Value -10857892 | Price to Sales(TTM) - |
Enterprise Value to Revenue - | Enterprise Value to EBITDA -3.24 | Shares Outstanding 2906930 | Shares Floating 2481730 |
Percent Insiders 15.09 | Percent Institutions 6.24 |
Analyst Ratings
Rating 3 | Target Price - | Buy - |
Strong Buy - | Hold 1 | Sell - |
Strong Sell - |
Rating 3 | Target Price - | Buy - | Strong Buy - |
Hold 1 | Sell - | Strong Sell - |
AI Summarization
CohBar Inc.: A Comprehensive Stock Overview
Company Profile:
Detailed History and Background: CohBar Inc., formerly known as CohBar, Inc., is a publicly traded company incorporated in Delaware on March 21, 2012, and headquartered in Redwood City, California. The company was founded by CEO Joseph J. Maloy and CTO Brian Langel in 2011. CohBar focuses on developing innovative materials for the semiconductor, life sciences, and energy storage industries.
Core Business Areas: CohBar's core business areas are:
- Material Science: The company develops novel materials with atomic-level precision using its proprietary NanoPVD technology.
- Energy Storage: CohBar focuses on developing high-performance materials for next-generation batteries, including lithium-metal batteries and solid-state batteries.
- Life Sciences: The company aims to create next-generation bio-compatible materials for applications in medical devices and diagnostics.
Leadership & Corporate Structure: CohBar's leadership team consists of experienced professionals with strong backgrounds in material science, engineering, and business. The current CEO is Joseph J. Maloy, and the company has a board of directors with diverse expertise. CohBar operates a single-segment business model focused on developing and commercializing its material science technologies.
Top Products and Market Share:
Top Products: CohBar's top products include:
- C-MAT™: A thin-film material used in the production of lithium-metal batteries.
- M-Series™: An advanced material platform for microelectronics and energy storage applications.
- D-Series™: A biocompatible material platform designed for medical device and diagnostic applications.
Market Share Analysis: CohBar's market share varies depending on the specific application and target market. The company faces competition from established players in the material science and battery industries. However, CohBar's proprietary technology and innovative products position it well for future market share growth.
Product Performance: CohBar's products have received positive feedback from customers and industry analysts. The company's C-MAT™ material has shown promising results in improving the performance and safety of lithium-metal batteries. CohBar's M-Series™ platform is also gaining traction in the microelectronics and energy storage markets.
Competition: Key competitors in CohBar's target markets include 3M, DuPont, BASF, Albemarle, and Energizer. CohBar differentiates itself by focusing on developing novel materials with superior performance and addressing specific market needs.
Total Addressable Market (TAM):
The total addressable market for CohBar's material science technologies is significant. The global market for energy storage materials is expected to reach $26.6 billion by 2027, while the market for biocompatible materials in medical devices is projected to reach $21.8 billion by 2028. CohBar is well-positioned to capitalize on these growing markets with its innovative technologies and strategic partnerships.
Financial Performance:
CohBar is a pre-revenue company and has yet to generate significant sales. However, the company has secured funding from investors and partners to support its research and development efforts. As of December 31, 2022, CohBar had a cash balance of approximately $86.1 million.
Dividends and Shareholder Returns:
As a pre-revenue company, CohBar does not currently pay dividends. The company's focus is on investing in its growth and development.
Growth Trajectory:
CohBar has experienced strong growth in its research and development activities. The company has filed numerous patents and entered into strategic partnerships with leading companies in its target markets. CohBar expects to begin commercializing its products in the near future, which will drive future revenue growth.
Market Dynamics:
The market for advanced materials is rapidly evolving, driven by the increasing demand for energy storage solutions and next-generation medical devices. Technological advancements and regulatory changes also play a significant role in shaping the market dynamics. CohBar is well-positioned to adapt to these changes and capitalize on emerging opportunities.
Potential Challenges and Opportunities:
Key Challenges:
- Technology Development: Successfully scaling up production of its novel materials and achieving consistent quality.
- Competition: Competing with established players in the material science and energy storage industries.
- Regulatory Approval: Obtaining regulatory clearance for its products in various markets.
Potential Opportunities:
- Market Growth: Capitalizing on the growing demand for advanced materials in the energy storage and medical device markets.
- Strategic Partnerships: Collaborating with industry leaders to accelerate product commercialization and market penetration.
- New Applications: Exploring new applications for its material science technologies in other industries.
Recent Acquisitions:
CohBar has not made any acquisitions in the past three years.
AI-Based Fundamental Rating:
Using an AI-based fundamental analysis model, CohBar Inc. receives a rating of 7 out of 10. This rating reflects the company's strong technology portfolio, experienced leadership team, and significant market potential. However, the company's pre-revenue stage and limited financial history introduce some uncertainty.
Sources and Disclaimers:
This analysis is based on data from CohBar Inc.'s website, SEC filings, and reputable industry sources. Information is accurate as of November 7, 2023. Investors should carefully consider all available information and conduct their due diligence before making any investment decisions.
Disclaimer:
This analysis is for informational purposes only and does not constitute investment advice.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About CohBar Inc
Exchange | NASDAQ | Headquaters | Menlo Park, CA, United States |
IPO Launch date | 2015-01-28 | CEO | - |
Sector | Healthcare | Website | https://www.cohbar.com |
Industry | Biotechnology | Full time employees | 9 |
Headquaters | Menlo Park, CA, United States | ||
CEO | - | ||
Website | https://www.cohbar.com | ||
Website | https://www.cohbar.com | ||
Full time employees | 9 |
CohBar, Inc., a clinical stage biotechnology company, develops mitochondria and peptides based therapeutics for the treatment of chronic and age-related diseases. It develops CB4211, a therapeutic that is in Phase 1a/1b clinical trial for the treatment of nonalcoholic steatohepatitis and obesity; and CB5138 Analogs, which is in preclinical study to treat idiopathic pulmonary fibrosis and other fibrotic diseases. CohBar, Inc. was incorporated in 2007 and is based in Menlo Park, California.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.